Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 26Gynecologic 5Head & Neck 2Dermatologic 2Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Genitourinary 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 1699Glioblastoma 1307Glioma 992Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 383Gliosarcoma 286Oligodendroglioma 237Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 127Melanoma 118Sarcoma 116Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 94Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Interventions

lentiviral minigene vaccine of COVID-19 coronavirus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Microsatellite Instability × CNS × Clear all
NCT06043232 2023-09-21

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

Huashan Hospital

Unknown
360 enrolled
CNS

Glioblastoma, Glioma, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡